Medical Imaging

In 2011 the US Department of Commerce identified the Medical Imaging & Technology Alliance as one of five industries with particularly strong export prospects to India and China deserving of special assistance. This is just one indicator of the rapid progress being made in medical imaging technology and services in healthcare systems all over the world. Whether your interest lies in angiography, mammography, radiography or computer tomography (CT); or optical microscopes, x-ray equipment, ultrasound technology or 3D visualization – you will find the latest data and insights compiled by experts ‘on the ground’ all over the globe in the following pages. You can also investigate the latest technologies and market strategies of key medical industry players such as Siemens, McKesson, Bayer Healthcare, Canon and GE Healthcare. Show Less ... more

• Shandong Weigao Group Medical Polymer Co Ltd,(SHWGF) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Shandong Weigao Group Medical Polymer Co Ltd (SHWGF), plus vital industry benchmarks and extensive operating...

• Solta Medical, Inc.,(SLTM) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Solta Medical, Inc. (SLTM), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• WellCare Health Plans Inc,(WCG) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for WellCare Health Plans Inc (WCG), plus vital industry benchmarks and extensive operating ratios, along with...

• Yaletown Capital Corporation,(YCC) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Yaletown Capital Corporation (YCC), plus vital industry benchmarks and extensive operating ratios, along with...

• BG Medicine, Inc.,(BGMD) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for BG Medicine, Inc. (BGMD), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• BioLife Solutions Inc.,(BLFS) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for BioLife Solutions Inc. (BLFS), plus vital industry benchmarks and extensive operating ratios, along with an...

• LCA-Vision Inc,(LCAV) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for LCA-Vision Inc (LCAV), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• McKesson Corporation,(MCK) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for McKesson Corporation (MCK), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• Medipal Holdings Corp,(MAHLY) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Medipal Holdings Corp (MAHLY), plus vital industry benchmarks and extensive operating ratios, along with an...

• Luxottica Group SpA,(LUX) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Luxottica Group SpA (LUX), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• MAKO Surgical Corp,(MAKO) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for MAKO Surgical Corp (MAKO), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• Merck & Co Inc,(MRK) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Merck & Co Inc (MRK), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• Misonix Inc,(MSON) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Misonix Inc (MSON), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• Nano Mask Inc,(NANM) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Nano Mask Inc (NANM), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• NeuroMetrix Inc,(NURO) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for NeuroMetrix Inc (NURO), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• Olympus Corporation,(OCPNY) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Olympus Corporation (OCPNY), plus vital industry benchmarks and extensive operating ratios, along with an...

• GW Pharmaceuticals PLC,(GWPRF) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for GW Pharmaceuticals PLC (GWPRF), plus vital industry benchmarks and extensive operating ratios, along with...

• HCA Holdings Inc,(HCA) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for HCA Holdings Inc (HCA), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• HealthSouth Corp,(HLS) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for HealthSouth Corp (HLS), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• Hill-Rom Holdings Inc,(HRC) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Hill-Rom Holdings Inc (HRC), plus vital industry benchmarks and extensive operating ratios, along with an...

• HST Global, Inc.,(HSTC) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for HST Global, Inc. (HSTC), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• Incyte Corp,(INCY) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Incyte Corp (INCY), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• Bristol-Myers Squibb Co,(BMY) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Bristol-Myers Squibb Co (BMY), plus vital industry benchmarks and extensive operating ratios, along with an...

• Brookdale Senior Living Inc,(BKD) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Brookdale Senior Living Inc (BKD), plus vital industry benchmarks and extensive operating ratios, along with...

• Strike Axe Inc.,(SKAX) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Strike Axe Inc. (SKAX), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• Stryker Corp,(SYK) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Stryker Corp (SYK), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• Teva Pharmaceutical Industries Ltd,(TEVA) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Teva Pharmaceutical Industries Ltd (TEVA), plus vital industry benchmarks and extensive operating ratios,...

• MEDNAX Inc,(MD) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for MEDNAX Inc (MD), plus vital industry benchmarks and extensive operating ratios, along with an analysis of...

• Medtronic Inc,(MDT) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Medtronic Inc (MDT), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• MIV Therapeutics, Inc.,(MIVI) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for MIV Therapeutics, Inc. (MIVI), plus vital industry benchmarks and extensive operating ratios, along with an...

• MRI Interventions Inc,(MRIC) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 47
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for MRI Interventions Inc (MRIC), plus vital industry benchmarks and extensive operating ratios, along with an...

• Nordion Inc,(NDZ) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Nordion Inc (NDZ), plus vital industry benchmarks and extensive operating ratios, along with an analysis of...

• Novartis AG,(NVS) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Novartis AG (NVS), plus vital industry benchmarks and extensive operating ratios, along with an analysis of...

• Theragenics Corp,(TGX) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Theragenics Corp (TGX), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• Urologix, Inc.,(ULGX) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Urologix, Inc. (ULGX), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• Uroplasty Inc.,(UPI) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Uroplasty Inc. (UPI), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• Biosensors International Group Ltd.,(BSNRF) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Biosensors International Group Ltd. (BSNRF), plus vital industry benchmarks and extensive operating ratios,...

• Biosyntech, Inc.,(BSYI) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Biosyntech, Inc. (BSYI), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• Spectranetics Corp,(SPNC) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Spectranetics Corp (SPNC), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• Spring Creek Healthcare Systems Inc.,(SCRK) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Spring Creek Healthcare Systems Inc. (SCRK), plus vital industry benchmarks and extensive operating ratios,...

• Symmetry Medical Inc,(SMA) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Symmetry Medical Inc (SMA), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• Takeda Pharmaceutical Company Ltd,(TKPHF) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Takeda Pharmaceutical Company Ltd (TKPHF), plus vital industry benchmarks and extensive operating ratios,...

• Transcend Services Inc,(TRCR) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 46
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Transcend Services Inc (TRCR), plus vital industry benchmarks and extensive operating ratios, along with an...

• Trimedyne, Inc.,(TMED) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Trimedyne, Inc. (TMED), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• Volcano Corporation,(VOLC) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Volcano Corporation (VOLC), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• Walgreen Co,(WAG) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Walgreen Co (WAG), plus vital industry benchmarks and extensive operating ratios, along with an analysis of...

• Patient Home Monitoring Corp,(PHM) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Patient Home Monitoring Corp (PHM), plus vital industry benchmarks and extensive operating ratios, along with...

• Vasomedical, Inc.,(VASO) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Vasomedical, Inc. (VASO), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• Ventripoint Diagnostics Ltd.,(VPT) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Ventripoint Diagnostics Ltd. (VPT), plus vital industry benchmarks and extensive operating ratios, along with...

• Patient Safety Technologies, Inc.,(PSTX) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Patient Safety Technologies, Inc. (PSTX), plus vital industry benchmarks and extensive operating ratios, along...